1672-2809
2011 Issue 21
Status of structure-activity relationship of dipeptidyl peptidase-4 inhibitor
huang jian quan ; wang guan chun
huang jian quan ; wang guan chun
..............page:14-20
Importance of DPP-4-selective inhibition
lu zu qian ; xu zhang rong
lu zu qian ; xu zhang rong
..............page:8-9
Insulin Degludec reduces the risk of hypoglycemia
guo xiao zuo
guo xiao zuo
..............page:56-58
Influence of DPP-4 inhibitors on compliance for treatment of tyte 2 diabetes
li chun jun ; zhang qiu mei ; yu de min
li chun jun ; zhang qiu mei ; yu de min
..............page:42-45
Use of a new basal insulin with a bolus boost (IDegAap) for insulin treatment barriers
hong tian pei
hong tian pei
..............page:60-63
The hypoglycemic mechanism and effect of DPP-4 inhibitors
zhang jun qing
zhang jun qing
..............page:27-32
..............page:65-67
DPP-4 inhibitors: milepost for treatment of diabetes
liao er yuan
liao er yuan
..............page:6-7
Adverse drug reaction of DPP-4 inhibitors
hu yuan yuan ; ye shan dong
hu yuan yuan ; ye shan dong
..............page:46-49
Research status and reflection of relationship between oxidative stress and type 2 diabetes
huang hai ; zhu kai si
huang hai ; zhu kai si
..............page:50-52
Pharmacokinetics of dipeptidyl peptidase-4 inhibitors
zhao min ; zhao xue zeng
zhao min ; zhao xue zeng
..............page:10-13,20
..............page:64,4-5
The glycemic control status of outpatients with type 2 diabetes mellitus in Liaoyang City
YU Xiao-hua;LIU Fang
YU Xiao-hua;LIU Fang
..............page:53-55,63
Fit and avoid patients of DPP-4 inhibitors in treatment of type 2 diabetes
song dian ping ; yang jing jing ; yan wei
song dian ping ; yang jing jing ; yan wei
..............page:38-41
Non-glycemic effectes of DPP-4 inhibitors
yan sheng li ; zhang sha sha
yan sheng li ; zhang sha sha
..............page:33-37
Therapeutic regimens of DPP-4 inhibitors
yang yan ; tong nan wei
yang yan ; tong nan wei
..............page:21-26,32